Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
35.44
+1.23 (3.60%)
At close: Oct 9, 2026, 4:00 PM EDT
35.57
+0.13 (0.37%)
After-hours: Oct 9, 2026, 7:55 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $25.6 billion as of October 9, 2026. It is the 971st most valuable company in the world and the 404th biggest in the United States. Its market cap has increased by 131.14% in one year.
Market Cap
25.60B
Enterprise Value
21.86B
1-Year Change
131.14%
Global Rank
Country Rank
#404 United States
Category
ChartMarket Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $25.60B, an increase of 4,699.45%. That is a compound annual growth rate of 94.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 25.60B | 69.62% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 40.67B |
| BeOne Medicines AG | 40.30B |
| Royalty Pharma | 32.73B |
| Alnylam Pharmaceuticals | 31.13B |
| BioNTech SE | 24.36B |
| Incyte | 22.86B |
| Insmed | 21.97B |
| Genmab | 21.89B |